[Romosozumab (osteoporosis) - Addendum to Commission A20-24]
Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018003726
German
Original Title:
Romosozumab (Osteoporose) - Addendum zum Auftrag A20-24
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/a20-67.html
Year Published:
2020
URL for published report:
https://www.iqwig.de/download/a20-67_romosozumab_addendum-zum-auftrag-a20-24_v1-0.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Osteoporosis
- Osteoporosis, Postmenopausal
- Bone Density Conservation Agents
- Antibodies, Monoclonal
Keywords
- Romosozumab
- Osteoporosis - Postmenopausal
- Benefit Assessment
- NCT01631214
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.